Mitochondrial Homeostasis in Diabetic Cardiomyopathy: From Dysfunction to Therapeutic Strategies
Antioxidants · 22.03.2026 · 15 (3) · 399
DOI: 10.3390/antiox15030399 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 22.03.2026. Verfasst von Yafei Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Center, Peking University First Hospital, Beijing 100034, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Natural Science Foundation, National Science and Technology Major Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Diabetic cardiomyopathy is a specific form of heart dysfunction that occurs in diabetic patients independent of other cardiomyopathies such as coronary artery disease. It significantly contributes to heart failure and mortality in this population. The pathogenesis of diabetic cardiomyopathy mainly includes oxidative stress, inflammatory response, apoptosis and disrupted mitochondrial homeostasis. Mitochondrial homeostasis, encompassing mitochondrial dynamics, mitochondrial oxidative metabolism and mitophagy, is regulated by a variety of signaling pathways and plays a pivotal role in maintaining the normal function of cardiomyocytes. At present, the exact mechanisms underlying diabetic cardiomyopathy pathogenesis remain unclear, and effective prevention and treatment methods are lacking. This review therefore expounds the pathogenesis of diabetic cardiomyopathy from the perspective of mitochondrial homeostasis, providing new approaches to clinical management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Center, Peking University First Hospital, Beijing 100034, China.
- Department of Endocrinology, Peking University First Hospital, Beijing 100034, China.
- Department of Cardiology, Heart Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
- Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Förderung
- Beijing Municipal Natural Science Foundation
- National Science and Technology Major Project
- National Natural Science Foundation of China
- Beijing Physician-Scientist Training Program
- National High Level Hospital Clinical Research Funding (Interdisciplinary Research Project of Peking University First Hospital)
- Chinese Cardiovascular Asso-ciation-Natural lipid-lowering drugs fund
- China Endocrine and Metabo-lism Young Scientific Talent Research Project
- China Diabetes Young Scientific Talent Research Project
Zitieren
APA
Huang, Y., Zou, W., Jiang, X., Cheng, J., & Zheng, J. (2026). Mitochondrial Homeostasis in Diabetic Cardiomyopathy: From Dysfunction to Therapeutic Strategies. Antioxidants, 15(3), 399. https://doi.org/10.3390/antiox15030399
Vancouver
Huang Y, Zou W, Jiang X, Cheng J, Zheng J. Mitochondrial Homeostasis in Diabetic Cardiomyopathy: From Dysfunction to Therapeutic Strategies. Antioxidants. 2026;15(3):399. doi:10.3390/antiox15030399
BibTeX
@article{Huang2026,
author = {Huang, Yafei and Zou, Wenyu and Jiang, Xindi and Cheng, Jing and Zheng, Jia},
title = {Mitochondrial Homeostasis in Diabetic Cardiomyopathy: From Dysfunction to Therapeutic Strategies},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {3},
pages = {399},
doi = {10.3390/antiox15030399}
}
EUVIMED